Access cutting-edge heart failure treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access heart failure specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 of the Base Period. The primary hypothesis is that vericiguat is superior to placebo in reducing NT-proBNP at Week 16 of the Base Period.
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this heart failure clinical trial in St Louis, MO
If you're searching for heart failure treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.